Cardiac contractility modulation (CCM) is an innovative device-based therapy designed to enhance myocardial performance in patients with heart failure, particularly those with reduced ejection ...

The U.S. Centers for Medicare & Medicaid Services (CMS) has issued a draft coverage memo for cardiac contractility modulation (CCM), which offers coverage with evidence development for the company’s ...

Impulse Dynamics previously posted a $136 million funding round in February 2024. This year the company has gained Medicare reimbursement and a Category 1 CPT code for its heart failure therapy.

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...

The backlog of requests for Medicare national coverage analyses is a matter of record, but a new analysis highlights how deep that backlog runs. CMS declared it will review a petition from Impulse ...